Close Menu

NEW YORK – Blood collection device manufacturer Boston Microfluidics said today that it has closed a $17.5 million Series A financing round to support its R&D initiatives and continue improving its existing product line.

Working with partners, the firm offers collection devices that can be used at home, "making it easier for people to gain access to tests so that they can proactively monitor their health," the firm's CEO Brandon Johnson said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.